Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. - Wikidata - wikimedia - TriplyDB

Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.

Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.

http://www.wikidata.org/entity/Q40345414

about

H pylori antibiotic resistance: prevalence, importance, and advances in testing High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala Lumpur Primary Antibiotic Resistance of Helicobacter pylori in China.Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska Native persons from 2000 to 2008 Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France.Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR Helicobacter pylori detection and antimicrobial susceptibility testing.Use of Alignment-Free Phylogenetics for Rapid Genome Sequence-Based Typing of Helicobacter pylori Virulence Markers and Antibiotic Susceptibility Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan.High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones.Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.Effective regimens for the treatment of Helicobacter pylori infection.Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies.Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014).Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey Review article: the global emergence of Helicobacter pylori antibiotic resistance.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.Current recommendations for Helicobacter pylori therapies in a world of evolving resistance.Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication.The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials.Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal.MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION, DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION.Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.Should quinolones come first in Helicobacter pylori therapy?Quinolone resistance in Helicobacter pylori isolates in Germany.Helicobacter pylori and antibiotic resistance.Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation.Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.From Nobel to no cure: a case for monitoring antibiotic resistance in the gastric pathogen Helicobacter pylori.Point Mutations at gyrA and gyrB Genes of Levofloxacin-Resistant Helicobacter pylori Isolates in the Esophageal Mucosa from a Venezuelan Population.

P2860

Q24685864-042AE894-2998-48A4-A0A1-F3F2DEEADB91 Q26771197-10CBDC69-4B05-457C-9C7D-0F76BF06B705 Q28540466-BFB0BA5C-CC11-4F36-A302-845652AFE719 Q30235219-DCD81315-30BB-41AA-A992-5064FAE85808 Q33580515-B73E122E-6C3F-4B51-B470-4CE11E35E66D Q33639114-0A4AAC36-0329-4AC6-A7D8-202320E53E29 Q33769945-500856EF-4784-4495-B793-FDABA652ED00 Q34510388-21ED8D4A-475F-40A6-8DDF-7215105B0134 Q34983201-826057A2-3C4F-4960-A32C-946928A2BE17 Q35104855-319DFADA-CF5F-4781-9C03-2C60F4DE6D80 Q35273580-4C047052-9EE8-4981-8DE9-7430EC7B9898 Q35666513-958511E7-F7BE-4F48-9E7F-BE6EA4C04F57 Q35690423-12B2CC06-D67C-48D5-84EB-04824035C6E5 Q35783436-44E1D753-FBF9-4E49-841D-9CB294A455FE Q35968635-DAADF575-6485-49B6-B44F-CDF96D44E212 Q36171308-80CE7305-CDB9-4304-B0DE-BD74668AF4BE Q36290512-525515DD-7A21-4FDC-9005-4ED27457592C Q36556466-0E60CD23-91CE-45FF-A96D-8384D9131F0E Q36568724-751D1BA1-483C-4989-9A8E-987129DA6662 Q36979151-C4A99BB8-150A-4EB5-81EC-E9DC6CC4640F Q37123605-3AC1C2C7-838B-424B-9607-B8DC5B88A53E Q37232726-FDFD9590-18D2-4D47-97F0-F7E54C02E466 Q37340339-8F686C93-C002-45CA-81A6-F5E66009243C Q37378899-B83A99C2-4477-4F1B-8F91-14BE1E5F5B07 Q37410463-6482F04C-86C7-4F62-91AD-4BC6E3912116 Q37591509-F8AAA283-7DBA-40B2-B406-E12A1F751D0D Q38029324-CE087302-28A7-4DB1-98E0-1254357C1CB4 Q38125597-72B206BC-3AE7-428C-A12A-E58030306EEC Q39715113-48164993-E8A1-4C26-BE44-2929D04E12B3 Q40382489-9D9919BE-654A-4CC8-A95D-3F7E0B4395C8 Q41121067-7A5AB600-99CC-47DB-B8D7-1ADAF38A0679 Q41807465-7D7C4631-9344-4765-8D0B-2AD8EA48ECFB Q42112320-8065F9B4-9688-4FFD-A32C-99203520712C Q42735860-07E08EE0-CAA5-40C5-9582-E1198D988EEB Q43153504-F26BD4A6-DAA7-425D-98EA-49A52BF61DE7 Q44115534-8FBF4C07-3952-4742-BF29-D54BE8454B67 Q44790817-2858EC93-6891-4597-87B6-F3EC0F7FBECA Q44946806-2D8D8A93-6B66-477E-BE5A-58D4672F99E3 Q48336533-A0F22303-4BE4-400B-8AAE-02A98CDDD9B4 Q50192326-EEABD940-6DBE-4470-B8E2-DE71A9211230

P2860

Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.

http://www.wikidata.org/entity/Q40345414

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Single and double mutations in ...... stance in Helicobacter pylori.

@en

type

label

Single and double mutations in ...... stance in Helicobacter pylori.

@en

prefLabel

Single and double mutations in ...... stance in Helicobacter pylori.

@en

P1433

Q40345414-5AA1B2D0-60E7-43CB-B420-AA6D6C9AEA0C

P1476

Q40345414-1B32C662-11C9-4FDB-BE9C-341F0D912A5E

P2093

Q40345414-10B879C5-F5B1-48CC-B890-53A6D61480EF

Q40345414-3D53FD0D-0C36-44B9-B7B3-AF9A87ECC43F

Q40345414-7E976ECB-3A2E-4E62-8094-2761E4D210F2

Q40345414-A228F0A7-03AC-4ADE-858C-00E258CDEC08

Q40345414-AA697FD2-E00B-4878-8225-734C75D84383

P2860

Q40345414-17B1A0EB-6C28-495A-99AF-50AC8E97BE19

Q40345414-52E7B1B9-96D6-447D-AD58-6F6FD6781B59

Q40345414-53E437AC-7A1C-47B8-90B4-08C8114A229B

Q40345414-8B1B7A7D-61AB-4256-95D3-EA28A655683A

Q40345414-90E6BD9C-88F0-431E-BC58-D1A6672ABA81

Q40345414-9C93B550-F662-4F91-A54F-EC3440F9AAE3

Q40345414-BBDF7535-C8E5-435F-8B97-CFF483FE2F23

Q40345414-C4952E4B-B907-4282-8495-E20909E21000

Q40345414-D3DB312E-0657-4F87-AC5A-93F4BD33171B

Q40345414-F6E711C0-0563-419C-8D0B-BCEF459110A0

P304

Q40345414-D82AE631-4DC4-4606-A8E5-8AE0E86FE359

P31

Q40345414-624937DF-4F0F-4D39-AC46-C6B1FF9832B1

P356

Q40345414-9FD390C8-DC6E-4D50-BB99-54FA46712CD9

P407

Q40345414-C70B4EC4-B953-4F26-A8B0-E100D6BE7FB5

P433

Q40345414-ADB2F22A-B381-4AE7-93C5-CF10B2D697B7

P478

Q40345414-6E0B7605-0DFC-410A-B2E5-F7D65AB1C855

P577

Q40345414-68B8CF14-88D6-4D36-A2DE-F65822578433

P698

Q40345414-9B3A192D-6A8A-4FB5-B523-1A136382F5B4

P921

Q40345414-3212ABFC-1A30-4B75-8A86-59B213441904

P932

Q40345414-7876BEE3-1380-458F-883F-824ECE6C5B7A

P356

AAC.47.12.3942-3944.2003

P1433

Antimicrobial Agents and Chemotherapy

P1476

Single and double mutations in ...... stance in Helicobacter pylori.

@en

P2093

Christine Lascols

http://www.w3.org/2001/XMLSchema#string

Claude-James Soussy

http://www.w3.org/2001/XMLSchema#string

Jacques Tankovic

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Petit

http://www.w3.org/2001/XMLSchema#string

Quentin Sculo

http://www.w3.org/2001/XMLSchema#string

P2860

The complete genome sequence of the gastric pathogen Helicobacter pylori

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori

Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro

Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori.

In vitro activity of gemifloxacin against Helicobacter pylori.

[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid]

Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.

Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori.

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.

P304

3942-3944

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.47.12.3942-3944.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14638505

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

296230

http://www.w3.org/2001/XMLSchema#string